Chemical activators of Olr1061 can induce its activation through various signaling pathways that converge on the modulation of cAMP levels within cells. Forskolin, a potent activator of adenylyl cyclase, directly increases cAMP levels, which in turn activates protein kinase A (PKA). Once activated, PKA can phosphorylate Olr1061, leading to its activation. Similarly, Isoproterenol, which binds to beta-adrenergic receptors, also stimulates adenylyl cyclase to generate cAMP, engaging PKA that subsequently can activate Olr1061. Epinephrine operates through the adrenergic receptors to elicit the same cascade, resulting in the activation of Olr1061 via PKA. Dopamine engages its D1 receptors, coupled to Gs proteins, to activate adenylyl cyclase, enhancing cAMP and initiating PKA, which then can activate Olr1061. Histamine acts through H2 receptors to increase cAMP via Gs proteins, activating PKA and consequently Olr1061.
Another way Olr1061 can be activated is by chemicals that prolong the presence of cAMP within the cellular environment. IBMX, for instance, inhibits phosphodiesterases, which are responsible for cAMP breakdown, thus sustaining PKA activity that leads to Olr1061 activation. Adenosine, engaging with A2 receptors linked to Gs proteins, leads to increased cAMP and PKA activation, which also results in the activation of Olr1061. Prostaglandin E2 and Glucagon both interact with their respective Gs protein-coupled receptors to activate adenylyl cyclase, thereby increasing cAMP and activating PKA, which in turn can phosphorylate and activate Olr1061. Beta-2 adrenergic agonists such as Terbutaline and Salbutamol stimulate adenylyl cyclase via Gs protein-coupled receptors, leading to increased cAMP, PKA activation, and subsequent phosphorylation of Olr1061. Lastly, Rolipram, by inhibiting phosphodiesterase 4, maintains elevated levels of cAMP, resulting in sustained PKA activity that can lead to the activation of Olr1061.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol binds to beta-adrenergic receptors, activating Gs proteins and stimulating adenylyl cyclase to produce cAMP. This cascade leads to the activation of PKA, which may phosphorylate and activate Olr1061. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages with adrenergic receptors to activate adenylyl cyclase via G proteins, raising cAMP levels and subsequently activating PKA. PKA can then phosphorylate Olr1061, leading to its activation. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine binds to its D1 receptors, which are coupled to Gs proteins, leading to the activation of adenylyl cyclase, an increase in cAMP levels, and the activation of PKA. PKA phosphorylation can activate Olr1061. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine interacts with H2 receptors that signal through Gs proteins to activate adenylyl cyclase, increasing cAMP and activating PKA, which can phosphorylate and activate Olr1061. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing the breakdown of cAMP, thereby sustaining PKA activity. Constant PKA activity may lead to continuous phosphorylation and activation of Olr1061. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine activates A2 receptors, which are coupled to Gs proteins, leading to adenylyl cyclase activation, cAMP accumulation, and PKA activation. PKA can phosphorylate and activate Olr1061. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 binds to E-prostanoid receptors linked to Gs proteins, stimulating adenylyl cyclase, raising cAMP levels, and activating PKA, which may phosphorylate and activate Olr1061. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline, a beta-2 adrenergic agonist, selectively stimulates adenylyl cyclase through Gs protein-coupled receptors, increasing cAMP and activating PKA, which is likely to phosphorylate and activate Olr1061. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol activates beta-2 adrenergic receptors, leading to Gs protein-mediated activation of adenylyl cyclase, an increase in cAMP, and subsequent PKA activation. PKA can phosphorylate and activate Olr1061. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels and sustained activity of PKA. PKA may then phosphorylate and activate Olr1061. | ||||||